Can weight training protect your brain from dementia?

Translate to Spanish or other 102 languages!

Engaging in more weight training may help lower dementia risk, new research suggests. Image for illustration purposes
- Advertisement -

Regular exercise is a known modifiable risk factor for dementia. 

A new study suggests that weight training may help protect the brains of older adults from dementia.

The benefits of weight training were also observed in those already showing signs of mild cognitive impairment. 

- Advertisement -

As of 2021, researchers estimate that about 57 million people Trusted Source globally were living with dementia — a neurological condition that impacts a person’s memory and thinking skills.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/can-weight-training-protect-brain-dementia-cognitive-decline?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-04-11&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen. FULL TO CAPACITY. NO MORE ROOM.

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

The Connection Between Diet and Breast Cancer Risk

October is Breast Cancer Awareness Month, and many people may be wondering how to lower their risk.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Simple Steps to Soothe Arthritis Pain

Mega Doctor News CLEVELAND CLINIC - Osteoarthritis is the most common form of...
- Advertisement -